PSIL Holdings Information

PSIL is an equity ETF with a total of 28 individual holdings. The top holdings are Atai Beckley stock at 12.73%, Mind Medicine (MindMed) at 7.63%, Neurocrine Biosciences at 7.18%, Alkermes at 6.99%, and COMPASS Pathways at 6.90%.

Total Holdings

Top 10 Percentage

70.38%

Asset Class

Equity

ETF Category

Miscellaneous Sector

Assets

18.12M

PE Ratio

n/a

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ATAI	Atai Beckley N.V.	12.73%	515,271
2	MNMD	Mind Medicine (MindMed) Inc.	7.63%	120,104
3	NBIX	Neurocrine Biosciences, Inc.	7.18%	8,472
4	ALKS	Alkermes plc	6.99%	40,839
5	CMPS	COMPASS Pathways plc	6.90%	228,025
6	RLMD	Relmada Therapeutics, Inc.	6.10%	441,088
7	SUPN	Supernus Pharmaceuticals, Inc.	6.04%	23,265
8	VTGN	Vistagen Therapeutics, Inc.	6.01%	260,978
9	ANRO	Alto Neuroscience, Inc.	5.42%	87,110
10	NRXP	NRx Pharmaceuticals, Inc.	5.37%	366,166
11	NEO: CYBN	Cybin Inc.	5.25%	159,982
12	GHRS	GH Research PLC	5.07%	67,731
13	CSE: DRUG	Bright Minds Biosciences Inc.	4.41%	15,329
14	STIM	Neuronetics, Inc.	3.24%	214,445
15	NEUP	Neuphoria Therapeutics Inc.	2.57%	106,043
16	CSE: QNTM	Quantum BioPharma Ltd.	2.31%	46,617
17	SILO	Silo Pharma, Inc.	1.57%	563,068
18	KTTA	Pasithea Therapeutics Corp.	1.15%	286,196
19	IXHL	Incannex Healthcare Inc.	1.09%	523,388
20	CMND	Clearmind Medicine Inc.	1.08%	249,198
21	TSX: NUMI	Numinus Wellness Inc.	1.03%	4,544,982
22	ENVB	Enveric Biosciences, Inc.	0.68%	16,973
23	TTTXX	BlackRock Treasury Trust Fund	0.17%	30,480
24	n/a	Cash	0.00%	1
25	n/a	Sage Therapeutics Cvr	0.00%	89,780

Showing 25 of 28 holdings

Subscribe to see the full list

Activate Now

As of Nov 5, 2025